96 related articles for article (PubMed ID: 30394035)
41. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
42. Establishment of a type II insulin-like growth factor receptor gene site-integrated SKBR3 cell line using CRISPR/Cas9.
Ma X; Cao R; Xiao H; Cao Z
Oncol Lett; 2020 Dec; 20(6):354. PubMed ID: 33123265
[TBL] [Abstract][Full Text] [Related]
43. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
44. CRISPR/Cas9-mediated gene manipulation to create single-amino-acid-substituted and floxed mice with a cloning-free method.
Ma X; Chen C; Veevers J; Zhou X; Ross RS; Feng W; Chen J
Sci Rep; 2017 Feb; 7():42244. PubMed ID: 28176880
[TBL] [Abstract][Full Text] [Related]
45. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
[TBL] [Abstract][Full Text] [Related]
46. Spermatogenic Cell-Specific Gene Mutation in Mice via CRISPR-Cas9.
Bai M; Liang D; Wang Y; Li Q; Wu Y; Li J
J Genet Genomics; 2016 May; 43(5):289-96. PubMed ID: 27210043
[TBL] [Abstract][Full Text] [Related]
47. Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators.
Bogerd HP; Kornepati AV; Marshall JB; Kennedy EM; Cullen BR
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7249-56. PubMed ID: 26668372
[TBL] [Abstract][Full Text] [Related]
48. Construction and Identification of the RNAi Recombinant Lentiviral Vector Targeting Human DEPDC7 Gene.
Liao Z; Wang X; Lin D; Zou Q
Interdiscip Sci; 2017 Sep; 9(3):350-356. PubMed ID: 27016254
[TBL] [Abstract][Full Text] [Related]
49. [Construction and identification of a HEK293 cell line with stable TrxR1 overexpression].
Lü X; Zhou Z; Zhu L; Zhou J; Huang H; Zhang C; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):554-560. PubMed ID: 35527491
[TBL] [Abstract][Full Text] [Related]
50. CRISPR/Cas9-mediated targeted mutagenesis in upland cotton (Gossypium hirsutum L.).
Janga MR; Campbell LM; Rathore KS
Plant Mol Biol; 2017 Jul; 94(4-5):349-360. PubMed ID: 28258551
[TBL] [Abstract][Full Text] [Related]
51. Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer.
Ahn J; Kim KH; Park S; Ahn YH; Kim HY; Yoon H; Lee JH; Bang D; Lee DH
Oncotarget; 2016 Sep; 7(39):63252-63260. PubMed ID: 27533081
[TBL] [Abstract][Full Text] [Related]
52. Targeted mutagenesis in soybean using the CRISPR-Cas9 system.
Sun X; Hu Z; Chen R; Jiang Q; Song G; Zhang H; Xi Y
Sci Rep; 2015 May; 5():10342. PubMed ID: 26022141
[TBL] [Abstract][Full Text] [Related]
53. Functional analysis of Bombyx Wnt1 during embryogenesis using the CRISPR/Cas9 system.
Zhang Z; Aslam AF; Liu X; Li M; Huang Y; Tan A
J Insect Physiol; 2015 Aug; 79():73-9. PubMed ID: 26070541
[TBL] [Abstract][Full Text] [Related]
54. Functional prediction of AMP deaminase 1 in Jingyuan chicken and evaluation of the biological activities of its expression vectors.
Huang Z; Wang J; Huang Z; Tang G; Lv G; Li D; Yang C
Int J Biol Macromol; 2024 Jun; 271(Pt 1):132546. PubMed ID: 38782330
[TBL] [Abstract][Full Text] [Related]
55. [Construction of a lentiviral vector carrying TRAIL gene and its infection efficiency to lymphoma cells in vitro].
Fu XR; Zhang XD; Zhang C; Zhao L; Wang BH; Zhang MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):900-5. PubMed ID: 22931651
[TBL] [Abstract][Full Text] [Related]
56. Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9.
Abrahimi P; Chang WG; Kluger MS; Qyang Y; Tellides G; Saltzman WM; Pober JS
Circ Res; 2015 Jul; 117(2):121-8. PubMed ID: 25940550
[TBL] [Abstract][Full Text] [Related]
57. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
[TBL] [Abstract][Full Text] [Related]
58. Single-step generation of gene knockout-rescue system in pluripotent stem cells by promoter insertion with CRISPR/Cas9.
Matsunaga T; Yamashita JK
Biochem Biophys Res Commun; 2014 Feb; 444(2):158-63. PubMed ID: 24462858
[TBL] [Abstract][Full Text] [Related]
59. Efficiency and Inheritance of Targeted Mutagenesis in Maize Using CRISPR-Cas9.
Zhu J; Song N; Sun S; Yang W; Zhao H; Song W; Lai J
J Genet Genomics; 2016 Jan; 43(1):25-36. PubMed ID: 26842991
[TBL] [Abstract][Full Text] [Related]
60. Molecular Dynamics of Cobalt Protoporphyrin Antagonism of the Cancer Suppressor REV-ERBβ.
Fakih TM; Kurniawan F; Yusuf M; Mudasir M; Tjahjono DH
Molecules; 2021 May; 26(11):. PubMed ID: 34071361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
